Paper41545779
Chemically modified and inactivated bacteria enable intra-biofilm drug delivery and long-term immunity against implant infections.
Yang C and 10 others. Nat Biomed Eng, 2026. Cited by 16 papers, by iCite.
Cite this record
ConductScience Library. Chemically modified and inactivated bacteria enable intra-biofilm drug delivery and long-term immunity against implant infections. Papers, record 41545779. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41545779
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Chemically modified and inactivated bacteria enable intra-biofilm drug delivery and long-term immunity against implant infections.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References73
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37258686 | Drug delivery strategies for antibiofilm therapy. | Nat Rev Microbiol | 2023 | https://conductscience.org/library/papers/37258686 | PubMed |
| 2 | 11166241 | Mechanisms of biofilm resistance to antimicrobial agents. | Trends Microbiol | 2001 | https://conductscience.org/library/papers/11166241 | PubMed |
| 3 | 35115704 | Tolerance and resistance of microbial biofilms. | Nat Rev Microbiol | 2022 | https://conductscience.org/library/papers/35115704 | PubMed |
| 4 | 35169289 | Skeletal infections: microbial pathogenesis, immunity and clinical management. | Nat Rev Microbiol | 2022 | https://conductscience.org/library/papers/35169289 | PubMed |
| 5 | 32813012 | How to Handle Concomitant Asymptomatic Prosthetic Joints During an Episode of Hematogenous Periprosthetic Joint Infection, a Multicenter Analysis. | Clin Infect Dis | 2021 | https://conductscience.org/library/papers/32813012 | PubMed |
| 6 | 35922483 | The biofilm life cycle: expanding the conceptual model of biofilm formation. | Nat Rev Microbiol | 2022 | https://conductscience.org/library/papers/35922483 | PubMed |
| 7 | 17694072 | The biological role of death and lysis in biofilm development. | Nat Rev Microbiol | 2007 | https://conductscience.org/library/papers/17694072 | PubMed |
| 8 | 27101516 | Genetic engineering of untransformable coagulase-negative staphylococcal pathogens. | Nat Protoc | 2016 | https://conductscience.org/library/papers/27101516 | PubMed |
| 9 | 36423303 | Engineering bacteria as interactive cancer therapies. | Science | 2022 | https://conductscience.org/library/papers/36423303 | PubMed |
| 10 | 37053311 | Engineered skin bacteria induce antitumor T cell responses against melanoma. | Science | 2023 | https://conductscience.org/library/papers/37053311 | PubMed |
| 11 | 26089520 | VACCINES. A mucosal vaccine against Chlamydia trachomatis generates two waves of protective memory T cells. | Science | 2015 | https://conductscience.org/library/papers/26089520 | PubMed |
| 12 | 35289640 | Mathematical Modeling for Evaluating Inherent Parameters Affecting UVC Decontamination of Indicator Bacteria. | Appl Environ Microbiol | 2022 | https://conductscience.org/library/papers/35289640 | PubMed |
| 13 | 29720707 | Implant infections: adhesion, biofilm formation and immune evasion. | Nat Rev Microbiol | 2018 | https://conductscience.org/library/papers/29720707 | PubMed |
| 14 | 32931252 | Space-Selective Chemodynamic Therapy of CuFe5O8 Nanocubes for Implant-Related Infections. | ACS Nano | 2020 | https://conductscience.org/library/papers/32931252 | PubMed |
| 15 | 27745970 | L-Arginine Modulates T Cell Metabolism and Enhances Survival and Anti-tumor Activity. | Cell | 2016 | https://conductscience.org/library/papers/27745970 | PubMed |
| 16 | 34616044 | Metabolic modulation of tumours with engineered bacteria for immunotherapy. | Nature | 2021 | https://conductscience.org/library/papers/34616044 | PubMed |
| 17 | 35649449 | Bacterially mediated drug delivery and therapeutics: Strategies and advancements. | Adv Drug Deliv Rev | 2022 | https://conductscience.org/library/papers/35649449 | PubMed |
| 18 | 31433955 | Mechanisms of DNA Uptake by Naturally Competent Bacteria. | Annu Rev Genet | 2019 | https://conductscience.org/library/papers/31433955 | PubMed |
| 19 | 7814343 | Genetic competence in Escherichia coli requires poly-beta-hydroxybutyrate/calcium polyphosphate membrane complexes and certain divalent cations. | J Bacteriol | 1995 | https://conductscience.org/library/papers/7814343 | PubMed |
| 20 | 22562126 | Calcium chloride made E. coli competent for uptake of extraneous DNA through overproduction of OmpC protein. | Protein J | 2012 | https://conductscience.org/library/papers/22562126 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42953337 | Heterojunction nanozyme achieve highly efficient antibacterial by cuproptosis-like death and ferroptosis-like death. | Bioact Mater | 2027 | https://conductscience.org/library/papers/42953337 | PubMed |
| 42764359 | Multidrug resistance, biofilm formation, and pathotype diversity of Escherichia coli isolated from diarrheic lambs in intensive sheep farms, Aksu, Xinjiang, China. | BMC Microbiol | 2026 | https://conductscience.org/library/papers/42764359 | PubMed |
| 42667089 | Organization from cell to tissue derived delivery systems for immunotherapy. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/42667089 | PubMed |
| 42293387 | Intelligent multimodal-energy-driven piezoelectric antibacterial platforms: From structural control to system-level diagnosis. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/42293387 | PubMed |
| 42231706 | Deciphering Augmented Dual-ROS-Driven Biofilm Eradication by Facilitating Long-Range Spatial Charge Decoupling in Polymer Carbon Dots. | Angew Chem Int Ed Engl | 2026 | https://conductscience.org/library/papers/42231706 | PubMed |
| 42111765 | An inflammation-targeted lipid nanoparticle inhibiting ferroptosis for spinal cord injury repair. | Mater Today Bio | 2026 | https://conductscience.org/library/papers/42111765 | PubMed |
| 42107053 | Targeting Golgi-STING Signaling to Reprogram Innate and Adaptive Immunity for the Treatment of Implant-Associated Infections. | Adv Sci (Weinh) | 2026 | https://conductscience.org/library/papers/42107053 | PubMed |
| 42028412 | Synergistic integration of biomaterials in orthopedic implantation for infection preventing and tissue engineering. | Regen Biomater | 2026 | https://conductscience.org/library/papers/42028412 | PubMed |
| 42005816 | Stimuli-responsive hydrogels for radiation-induced skin injury: from passive barriers to autonomous drug delivery systems. | Regen Biomater | 2026 | https://conductscience.org/library/papers/42005816 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41545779
GET https://conductscience.org/api/papers/v1/41545779/references?page=2